Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):1847–1850. doi: 10.1111/j.1476-5381.1991.tb12340.x

Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonists.

M J Dunne 1
PMCID: PMC1908199  PMID: 1680516

Abstract

1. The patch clamp technique has been used to characterize the effects of phentolamine, an unselective blocker of alpha 1- and alpha 2-adrenoceptors, on the electrical activity of isolated RINm5F insulin-secreting cells and the gating of ATP-regulated potassium (K+ATP) channels. 2. Current-clamp experiments carried out by use of both conventional whole-cell recordings and nystatin-perforated cells, have demonstrated that phentolamine (5-20 microM) in the complete absence of alpha-adrenoceptor agonists, caused a sharp depolarization of the cell membrane from approximately -66 mV to -42 mV. This depolarization was associated with the generation of calcium action potential-like spikes. In the continued presence of phentolamine, diazoxide (100 microM) reversed these effects by causing a hyperpolarization of the cell, thereby preventing Ca2+ spikes. 3. Unitary current events from K+ATP channels were recorded from both outside-out membrane patches and saponin permeabilized or open-cells. When added to either the inside or the outside of the plasma membrane, phentolamine (0.1-100 microM) blocked openings from these channels. The effects of phentolamine were rapid, sustained and fully reversible. Phentolamine was apparently a more effective blocker of channels from the inside than the outside of the membrane. 4. The KI value, corresponding to 50% inhibition of channels was estimated to be approximately 0.7 microM when phentolamine was added to the inside of the membrane and the Hill coefficient approximately 1. 5. Yohimbine (1-10 microM) and the chemically 2-substituted imidazoline alpha-adrenoceptor antagonists, antazoline (25 microM) and tolazoline (25 microM) were also found to block K+ATP channels in isolated patches of membrane.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashcroft F. M. Adenosine 5'-triphosphate-sensitive potassium channels. Annu Rev Neurosci. 1988;11:97–118. doi: 10.1146/annurev.ne.11.030188.000525. [DOI] [PubMed] [Google Scholar]
  2. Ashcroft S. J., Ashcroft F. M. Properties and functions of ATP-sensitive K-channels. Cell Signal. 1990;2(3):197–214. doi: 10.1016/0898-6568(90)90048-f. [DOI] [PubMed] [Google Scholar]
  3. Burr I. M., Marliss E. B., Stauffacher W., Renold A. E. Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas. J Clin Invest. 1971 Jul;50(7):1444–1450. doi: 10.1172/JCI106628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chan S. L., Morgan N. G. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur J Pharmacol. 1990 Jan 25;176(1):97–101. doi: 10.1016/0014-2999(90)90137-u. [DOI] [PubMed] [Google Scholar]
  5. Dunne M. J., Findlay I., Petersen O. H., Wollheim C. B. ATP-sensitive K+ channels in an insulin-secreting cell line are inhibited by D-glyceraldehyde and activated by membrane permeabilization. J Membr Biol. 1986;93(3):271–279. doi: 10.1007/BF01871181. [DOI] [PubMed] [Google Scholar]
  6. Dunne M. J., Illot M. C., Peterson O. H. Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line. J Membr Biol. 1987;99(3):215–224. doi: 10.1007/BF01995702. [DOI] [PubMed] [Google Scholar]
  7. Dunne M. J. Nutrient and pharmacological stimulation of insulin-secreting cells: marked differences in the onset of electrical activity. Exp Physiol. 1990 Nov;75(6):771–777. doi: 10.1113/expphysiol.1990.sp003459. [DOI] [PubMed] [Google Scholar]
  8. Dunne M. J. Protein phosphorylation is required for diazoxide to open ATP-sensitive potassium channels in insulin (RINm5F) secreting cells. FEBS Lett. 1989 Jul 3;250(2):262–266. doi: 10.1016/0014-5793(89)80734-3. [DOI] [PubMed] [Google Scholar]
  9. Dunne M. J., West-Jordan J. A., Abraham R. J., Edwards R. H., Petersen O. H. The gating of nucleotide-sensitive K+ channels in insulin-secreting cells can be modulated by changes in the ratio ATP4-/ADP3- and by nonhydrolyzable derivatives of both ATP and ADP. J Membr Biol. 1988 Sep;104(2):165–177. doi: 10.1007/BF01870928. [DOI] [PubMed] [Google Scholar]
  10. Efendić S., Cerasi E., Luft R. Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats. Diabetologia. 1975 Oct;11(5):407–410. doi: 10.1007/BF00429908. [DOI] [PubMed] [Google Scholar]
  11. Garrino M. G., Henquin J. C. B cell adrenoceptors and sulphonylurea-induced insulin release in mouse islets. Diabetologia. 1990 Mar;33(3):145–147. doi: 10.1007/BF00404040. [DOI] [PubMed] [Google Scholar]
  12. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  13. Henquin J. C., Charles S., Nenquin M., Mathot F., Tamagawa T. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli. Diabetes. 1982 Sep;31(9):776–783. doi: 10.2337/diab.31.9.776. [DOI] [PubMed] [Google Scholar]
  14. Lundquist I. Interaction of amines and aminergic blocking agents with blood glucose regulation. II. Alpha-adrenergic blockade. Eur J Pharmacol. 1972 May;18(2):225–235. doi: 10.1016/0014-2999(72)90246-4. [DOI] [PubMed] [Google Scholar]
  15. Malaisse W., Malaisse-Lagae F., Wright P. H., Ashmore J. Effects of adrenergic and cholinergic agents upon insulin secretion in vitro. Endocrinology. 1967 May;80(5):975–978. doi: 10.1210/endo-80-5-975. [DOI] [PubMed] [Google Scholar]
  16. Michel M. C., Insel P. A. Are there multiple imidazoline binding sites? Trends Pharmacol Sci. 1989 Sep;10(9):342–344. doi: 10.1016/0165-6147(89)90002-3. [DOI] [PubMed] [Google Scholar]
  17. Ostenson C. G., Pigon J., Doxey J. C., Efendic S. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes. J Clin Endocrinol Metab. 1988 Nov;67(5):1054–1059. doi: 10.1210/jcem-67-5-1054. [DOI] [PubMed] [Google Scholar]
  18. Petersen O. H., Dunne M. J. Regulation of K+ channels plays a crucial role in the control of insulin secretion. Pflugers Arch. 1989;414 (Suppl 1):S115–S120. doi: 10.1007/BF00582259. [DOI] [PubMed] [Google Scholar]
  19. Petersen O. H., Findlay I. Electrophysiology of the pancreas. Physiol Rev. 1987 Jul;67(3):1054–1116. doi: 10.1152/physrev.1987.67.3.1054. [DOI] [PubMed] [Google Scholar]
  20. Plant T. D., Henquin J. C. Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br J Pharmacol. 1990 Sep;101(1):115–120. doi: 10.1111/j.1476-5381.1990.tb12099.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Quast U., Cook N. S. Moving together: K+ channel openers and ATP-sensitive K+ channels. Trends Pharmacol Sci. 1989 Nov;10(11):431–435. doi: 10.1016/S0165-6147(89)80003-3. [DOI] [PubMed] [Google Scholar]
  22. Schulz A., Hasselblatt A. An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Sep;340(3):321–327. doi: 10.1007/BF00168517. [DOI] [PubMed] [Google Scholar]
  23. Smith M., Furman B. L. Augmentation of glucose induced insulin secretion by pertussis vaccine, phentolamine and benextramine: involvement of mechanisms additional to prevention of the inhibitory actions of catecholamines in rats. Acta Endocrinol (Copenh) 1988 May;118(1):89–95. doi: 10.1530/acta.0.1180089. [DOI] [PubMed] [Google Scholar]
  24. Trube G., Rorsman P., Ohno-Shosaku T. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Arch. 1986 Nov;407(5):493–499. doi: 10.1007/BF00657506. [DOI] [PubMed] [Google Scholar]
  25. Zünkler B. J., Lins S., Ohno-Shosaku T., Trube G., Panten U. Cytosolic ADP enhances the sensitivity to tolbutamide of ATP-dependent K+ channels from pancreatic B-cells. FEBS Lett. 1988 Nov 7;239(2):241–244. doi: 10.1016/0014-5793(88)80925-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES